Cost-Related Antihypertensive Medication Nonadherence: Action in the Time of COVID-19 and Beyond.
作者信息
Tajeu Gabriel S, Muntner Paul
机构信息
Department of Health Services Administration and Policy, Temple University, Philadelphia, Pennsylvania, USA.
Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
出版信息
Am J Hypertens. 2020 Sep 10;33(9):816-818. doi: 10.1093/ajh/hpaa085.
Abstract
摘要
相似文献
1
Cost-Related Antihypertensive Medication Nonadherence: Action in the Time of COVID-19 and Beyond.与费用相关的抗高血压药物治疗依从性不佳：在新冠疫情期间及之后采取的行动
Am J Hypertens. 2020 Sep 10;33(9):816-818. doi: 10.1093/ajh/hpaa085.
2
Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension.对合并高血压的新型冠状病毒肺炎患者使用血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体阻滞剂进行降压治疗。
Hypertens Res. 2020 Jun;43(6):588-590. doi: 10.1038/s41440-020-0433-1. Epub 2020 Mar 30.
3
Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence.在新冠疫情期间更换抗高血压治疗方案：为何我们应等待证据。
Eur Heart J. 2020 May 14;41(19):1857. doi: 10.1093/eurheartj/ehaa335.
4
Antihypertensive drugs and risk of COVID-19?抗高血压药物与新冠病毒病风险？
Lancet Respir Med. 2020 May;8(5):e30-e31. doi: 10.1016/S2213-2600(20)30153-3. Epub 2020 Mar 26.
5
Antihypertensive drugs and risk of COVID-19?抗高血压药物与新型冠状病毒肺炎风险？
Lancet Respir Med. 2020 May;8(5):e29. doi: 10.1016/S2213-2600(20)30156-9. Epub 2020 Mar 26.
6
Antihypertensive drugs and risk of COVID-19?抗高血压药物与新型冠状病毒肺炎风险？
Lancet Respir Med. 2020 May;8(5):e28. doi: 10.1016/S2213-2600(20)30158-2. Epub 2020 Mar 26.
7
Speculation is not evidence: antihypertensive therapy and COVID-19.推测并非证据：抗高血压治疗与新型冠状病毒肺炎
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(3):133-134. doi: 10.1093/ehjcvp/pvaa021.
8
Antihypertensive drugs and risk of COVID-19? - Authors' reply.抗高血压药物与2019冠状病毒病风险？——作者回复
Lancet Respir Med. 2020 May;8(5):e32-e33. doi: 10.1016/S2213-2600(20)30159-4. Epub 2020 Mar 26.
9
Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs.新型冠状病毒肺炎大流行中的肾素-血管紧张素系统抑制剂：抗高血压药物的影响
Eur Heart J. 2020 Jun 7;41(22):2067-2069. doi: 10.1093/eurheartj/ehaa487.
10
[Arterial hypertension and COVID-19 infections: A brief commentary].[动脉高血压与新冠病毒感染：简要评论]
Vnitr Lek. 2020 Spring;66(3):104-106.
引用本文的文献
1
Leveraging a multifaceted digital medication refill system on improving patients' medication adherence and reducing medication oversupply among elderly patients with hypertension.利用多方面的数字药物 refill 系统来提高老年高血压患者的药物依从性并减少药物供应过剩。
BMJ Open Qual. 2025 Jul 23;14(3):e002840. doi: 10.1136/bmjoq-2024-002840.
2
Review of Blood Pressure Control in Vulnerable Older Adults: The Role of Frailty and Sarcopenia.脆弱老年人群血压控制的综述：衰弱和肌肉减少症的作用
J Vasc Dis. 2025 Jun;4(2). doi: 10.3390/jvd4020018. Epub 2025 May 14.
3
Sex-based disparities with cost-related medication adherence issues in patients with hypertension, ischemic heart disease, and heart failure.高血压、缺血性心脏病和心力衰竭患者中与费用相关的药物依从性问题的性别差异。
J Am Med Inform Assoc. 2024 Dec 1;31(12):2924-2931. doi: 10.1093/jamia/ocae203.
4
Productivity-adjusted life-years and correlates of uncontrolled hypertension at two health facilities in Zambia.生产力调整生命年和赞比亚两家医疗机构未控制高血压的相关因素。
PLoS One. 2023 Dec 7;18(12):e0295401. doi: 10.1371/journal.pone.0295401. eCollection 2023.
5
When blood pressure refuses to budge: exploring the complexity of resistant hypertension.当血压顽固不降时：探索顽固性高血压的复杂性。
Front Cardiovasc Med. 2023 Jun 21;10:1211199. doi: 10.3389/fcvm.2023.1211199. eCollection 2023.
6
Adherence to antihypertensive treatment during the COVID-19 pandemic: findings from a cross-sectional study.2019年冠状病毒病大流行期间对抗高血压治疗的依从性：一项横断面研究的结果
Clin Hypertens. 2022 Dec 1;28(1):35. doi: 10.1186/s40885-022-00219-0.
7
Cost-Effectiveness of Recommendations From the Surgeon General's Call-to-Action to Control Hypertension.高血压控制：总医官呼吁采取行动降低成本效益分析。
Am J Hypertens. 2022 Mar 8;35(3):225-231. doi: 10.1093/ajh/hpab162.
8
Using the Health Belief Model to Explain the Patient's Compliance to Anti-hypertensive Treatment in Three District Hospitals - Dar Es Salaam, Tanzania: A Cross Section Study.运用健康信念模型解释坦桑尼亚达累斯萨拉姆市三家地区医院患者对降压治疗的依从性：一项横断面研究
East Afr Health Res J. 2021;5(1):50-58. doi: 10.24248/eahrj.v5i1.651. Epub 2021 Jun 11.
本文引用的文献
1
Association Between Cost-Related Medication Nonadherence and Hypertension Management Among US Adults.美国成年人中与费用相关的药物不依从与高血压管理之间的关联。
Am J Hypertens. 2020 Sep 10;33(9):879-886. doi: 10.1093/ajh/hpaa072.
2
Intersecting U.S. Epidemics: COVID-19 and Lack of Health Insurance.交叉的美国疫情：新冠疫情和缺乏医疗保险。
Ann Intern Med. 2020 Jul 7;173(1):63-64. doi: 10.7326/M20-1491. Epub 2020 Apr 7.
3
Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.2017ACC/AHA 高血压指南对美国人口的潜在影响。
Circulation. 2018 Jan 9;137(2):109-118. doi: 10.1161/CIRCULATIONAHA.117.032582. Epub 2017 Nov 13.
4
Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis.收缩压降低与心血管疾病和死亡风险：系统评价和网络荟萃分析。
JAMA Cardiol. 2017 Jul 1;2(7):775-781. doi: 10.1001/jamacardio.2017.1421.
5
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.《2017年心脏病和中风统计数据更新：美国心脏协会报告》
Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25.
6
Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries - United States, 2014.生命体征：2014 年，医疗保险处方药受益人群中抗高血压药物不依从的差异 - 美国。
MMWR Morb Mortal Wkly Rep. 2016 Sep 16;65(36):967-76. doi: 10.15585/mmwr.mm6536e1.
7
Reducing Medication Costs to Prevent Cardiovascular Disease: A Community Guide Systematic Review.降低药物成本以预防心血管疾病：社区指南系统评价
Prev Chronic Dis. 2015 Nov 25;12:E208. doi: 10.5888/pcd12.150242.
8
Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians.提高治疗依从性和临床疗效同时控制成本：更多使用仿制药的机会：美国医师学院临床指南委员会的最佳实践建议。
Ann Intern Med. 2016 Jan 5;164(1):41-9. doi: 10.7326/M14-2427. Epub 2015 Nov 24.
9
Recent trends in the dispensing of 90-day-supply prescriptions at retail pharmacies: implications for improved convenience and access.零售药店90天供应处方配药的近期趋势：对提高便利性和可及性的影响。
Am Health Drug Benefits. 2011 Mar;4(2):95-100.
10
Medication days' supply, adherence, wastage, and cost among chronic patients in Medicaid.医疗补助计划中慢性病患者的药物供应天数、依从性、浪费情况及费用
Medicare Medicaid Res Rev. 2012 Sep 19;2(3). doi: 10.5600/mmrr.002.03.a04. eCollection 2012.
Zotero 插件